Ellipses bought NLNK’s inventory of NLG207 related materials and gained the rights to develop and commercialize CRLX-301.
NewLink has the potential to receive future royalties or economic share related to NLG207.
NLNK shares are up 16.4% after hours to $2.27.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.